Locations:
Search IconSearch
May 26, 2017/Cancer/News & Insight

ASCO 2017 – Monday, June 5

Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASCO Annual Meeting

#ASCO_650x450

Monday, June 5

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

7:30 AM – 9:15 AM
Location: Hall D1

HIGHLIGHTS OF THE DAY SESSION: Highlights of the Day Session II

7:30 AM – 7:50 AM
Central Nervous System Tumors
David M. Peereboom, MD – Discussant

8:00 AM – 9:15 AM
Location: S406

EDUCATION SESSION: Pancreatic Adenocarcinoma: Improving Prevention and Survivorship
Davendra Sohal, MD, MPH – Chair

8:00 AM – 8:20 AM
Best Practices in Management of Resectable Pancreatic Cancer: Emerging Standards for Adjuvant Therapy and Surveillance
Davendra Sohal, MD, MPH – Chair

8:00 AM – 9:15 AM
Location: E253cd

MEET THE PROFESSOR SESSION: Brain Metastases: Utilizing Genomics and Combining Treatment Modalities

8:00 AM – 8:20 AM
Innovative Targeted Therapeutic Approaches in Brain Metastases
Manmeet Singh Ahluwalia, MD – Speaker

8:00 AM – 11:30 AM
Location: Hall A

POSTER SESSION: Hematologic Malignancies — Leukemia, Myelodysplastic Syndromes, and Allotransplant
Abstract 7061: Phase I/II trial of glasdegib in patients with primary or secondary myelofibrosis
Poster Board: #261
Aaron Thomas Gerds, MS, MD – First Author

1:15 PM – 4:45 PM
Location: Hall A

POSTER SESSION: Central Nervous System Tumors
Abstract 2071: What drives patient outcomes in brain metastases: Number, volume, or biology?
Poster Board: #313
Rupesh Kotecha, MD – First Author

POSTER SESSION: Genitourinary (Prostate) Cancer
Abstract 5041: Clinical activity and safety of ASN001, a selective CYP17 lyase inhibitor, administered without prednisone in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1/2 clinical trial
Poster Board: #115
Jorge A. Garcia, MD – First Author

Advertisement

POSTER SESSION: Head and Neck Cancer
Abstract 6072: Prognostic factors associated with benefit to post-operative chemotherapy: A National Cancer Data Base analysis
Poster Board: #60
Jessica Lyn Geiger, MD – First Author

POSTER SESSION: Health Services Research, Clinical Informatics, and Quality of Care
Abstract 6557: Increase in time to initiating cancer therapy and association with worsened survival in curative settings: A U.S. analysis of common solid tumors
Poster Board: #379
Alok A. Khorana, MD – First Author

Abstract 6558: Minority patient reported attitudes regarding tissue donation and participation in cancer research
Poster Board: #380
Davendra Sohal, MD, MPH – First Author

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad